| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.source_natural.com | |
| Market Cap | 100.16 Cr. | |
| Enterprise Value(EV) | 101.00 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 3.44 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 45.20 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 32.78 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 25.41 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 6.12 | Calculated using Price: 155.60 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.64 Cr. | 6,436,931 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007. | ||
| 1 Day |
|
-4.98% |
| 1 Week |
|
+2.33% |
| 1 Month |
|
+25.33% |
| 3 Month |
|
-0.26% |
| 6 Month |
|
+52.77% |
| 1 Year |
|
+37.70% |
| 2 Year |
|
+10.16% |
| 5 Year |
|
+29.94% |
| 10 Year |
|
+1125.20% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 5.86 | 3.86 | 8.31 | 22.42 | 10.87 | 12.40 | 17.65 | 29.40 | 16.92 | |
| Return on Capital Employed (%) | 3.56 | 3.22 | 8.94 | 20.40 | 11.67 | 13.56 | 20.89 | 33.08 | 26.23 | |
| Return on Assets (%) | 3.30 | 2.75 | 6.76 | 15.73 | 7.31 | 9.84 | 14.60 | 24.11 | 14.11 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 5 | 5 | 6 | 7 | 8 | 9 | 10 | 13 | 16 | 16 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
| Curr. Liab. | 0 | 1 | 1 | 4 | 3 | 2 | 3 | 4 | 3 | 3 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 6 | 6 | 7 | 11 | 11 | 10 | 12 | 16 | 19 | 20 | |
| Non Curr. Assets | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 5 | 7 | 7 | |
| Curr. Assets | 2 | 2 | 3 | 8 | 7 | 6 | 9 | 11 | 12 | 13 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 6 | 6 | 7 | 11 | 11 | 10 | 12 | 16 | 19 | 20 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 5 | 7 | 11 | 16 | 11 | 13 | 14 | 25 | 22 | 17 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total Income | 5 | 7 | 11 | 16 | 11 | 13 | 14 | 25 | 22 | 18 | |
| Total Expenditure | -4 | -6 | -10 | -14 | -9 | -11 | -11 | -21 | -18 | -14 | |
| PBIDT | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 5 | 4 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | |||
| Exceptional Items | 0 | ||||||||||
| PAT | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | |
| Adjusted EPS | 0 | 0 | 1 | 2 | 1 | 2 | 3 | 5 | 4 | 3 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | -1 | 0 | 3 | 0 | 4 | ||
| Cash Fr. Inv. | 0 | -1 | 0 | 0 | -2 | 0 | 0 | -1 | -2 | ||
| Cash Fr. Finan. | 0 | 0 | 0 | 0 | 2 | 0 | -2 | 0 | 0 | ||
| Net Change | 0 | 0 | 0 | 0 | -1 | 0 | 1 | -1 | 3 | ||
| Cash & Cash Eqvt | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 3 |
|
Sat, 07 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer With reference to the captioned subject and in compliance with Regulation 30 read with Para A of Part A of Schedule III of the SEBI (LODR) Regulations 2015 this is to inform you that Mrs. Sweta Gaur has tendered her resignation from the post of Company Secretary (KMP) of the Company w.e.f. 07th January 2023 (after the closing of business hours) for personal reasons and the same has been taken on record by the Board of Directors in the Board Meeting Held on 19th December 2022. |
|
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In accordance with regulation 74(5) SEBI Depositories and Participants) Regulations 2018 for the quarter ended December 2022 based on the certificate received from Venture Capital and corporate Investment Private Limited (RTA) which is enclosed herewith we hereby confirmed that no securities have received for dematerialisation/rematerialisation during the quarter 01.10.2022 to 31.12.2022 for our company. |
|
Wed, 04 Jan 2023
Announcement Under Regulation 30 This is in reference to your email dated January 03 2023 having reference no. L/SURV/ONL/PV/KS/ 2022-2023 / 2932. We wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and has not withheld any material information/event that in our opinion would have bearing on the price behaviour of the scrip. The Company shall continue to make applicable disclosures within the stipulated time.Therefore the movement in the share price of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such movement in price. |
| Mon, 30 Jan 2023 |
Opening at High
|
High Increase in 1 Month
|
High Increase in 6 Months
|
High Increase in 1 Year
|
Closing Near 100 SMA
|
Equities
M.F.
Sectors